Vitamin D therapy in chronic kidney disease and end stage renal disease

Michal L. Melamed, Ravi I. Thadhani

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.

Original languageEnglish (US)
Pages (from-to)358-365
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Volume7
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

Chronic Renal Insufficiency
Vitamin D
Chronic Kidney Failure
Ergocalciferols
Calcitriol
Cholecalciferol
Kidney Diseases
Therapeutics
Clinical Trials
Research
Population

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Vitamin D therapy in chronic kidney disease and end stage renal disease. / Melamed, Michal L.; Thadhani, Ravi I.

In: Clinical Journal of the American Society of Nephrology, Vol. 7, No. 2, 01.02.2012, p. 358-365.

Research output: Contribution to journalArticle

@article{66e2480f3aff491ca46c0ecadac518c0,
title = "Vitamin D therapy in chronic kidney disease and end stage renal disease",
abstract = "Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.",
author = "Melamed, {Michal L.} and Thadhani, {Ravi I.}",
year = "2012",
month = "2",
day = "1",
doi = "10.2215/CJN.04040411",
language = "English (US)",
volume = "7",
pages = "358--365",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "2",

}

TY - JOUR

T1 - Vitamin D therapy in chronic kidney disease and end stage renal disease

AU - Melamed, Michal L.

AU - Thadhani, Ravi I.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.

AB - Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.

UR - http://www.scopus.com/inward/record.url?scp=84857175985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857175985&partnerID=8YFLogxK

U2 - 10.2215/CJN.04040411

DO - 10.2215/CJN.04040411

M3 - Article

C2 - 22193236

AN - SCOPUS:84857175985

VL - 7

SP - 358

EP - 365

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 2

ER -